- $14.67bn
- $15.51bn
- $4.37bn
- 85
- 58
- 75
- 85
Annual income statement for Illumina, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2021 January 3rd | 2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,239 | 4,526 | 4,504 | 4,584 | 4,372 |
| Cost of Revenue | |||||
| Gross Profit | 2,203 | 3,154 | 2,744 | 2,972 | 2,861 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,659 | 4,649 | 5,573 | 8,763 | 5,205 |
| Operating Profit | 580 | -123 | -1,069 | -4,179 | -833 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 856 | 884 | -1,117 | -4,336 | -1,179 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 656 | 762 | -1,161 | -4,404 | -1,223 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 656 | 762 | -1,161 | -4,404 | -1,223 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 656 | 762 | -1,161 | -4,404 | -1,223 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.43 | 5.05 | -3.24 | -9.28 | -1.58 |